During the past decade, Reproductive Endocrine Unit, Massachusetts General Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reproductive Endocrine Unit, Massachusetts General Hospital" #1 collaborator was "National Institutes of Health (NIH)" with 2 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Reproductive Endocrine Unit, Massachusetts General Hospital" are "Cognitive Changes" (1 trials), "Fragile X Syndrome" (1 trials), "Healthy" (1 trials), "Healthy Volunteers" (1 trials) and "Memory Loss" (1 trials). Many other conditions were trialed in "Reproductive Endocrine Unit, Massachusetts General Hospital" in a lesser frequency.

Most popular intervention types in "Reproductive Endocrine Unit, Massachusetts General Hospital" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Estradiol oral capsule" (1 trials), "Follicle Aspiration" (1 trials), "Letrozole" (1 trials), "NAL-GLU GnRH antagonist" (1 trials) and "micronized progesterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Reproductive Endocrine Unit, Massachusetts General Hospital" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Reproductive Endocrine Unit, Massachusetts General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Reproductive Endocrine Unit, Massachusetts General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Reproductive Endocrine Unit, Massachusetts General Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".